Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target.

Authors:
Theo Battista Annarita Fiorillo Valerio Chiarini Ilaria Genovese Andrea Ilari Gianni Colotti

Cancers (Basel) 2020 Apr 6;12(4). Epub 2020 Apr 6.

Institute of Molecular Biology and Pathology, Italian National Research Council, Istituto di Biologia e Patologia Molecolari, Consiglio Nazionale delle Ricerche (IBPM-CNR), c/o Department of Biochemical Sciences, Sapienza University, P.le A.Moro 5, 00185 Rome, Italy.

The development of drug resistance is one of the main causes of failure in anti-cancer treatments. Tumor cells adopt many strategies to counteract the action of chemotherapeutic agents, e.g., enhanced DNA damage repair, inactivation of apoptotic pathways, alteration of drug targets, drug inactivation, and overexpression of ABC (Adenosine triphosphate-binding cassette, or ATP-binding cassette) transporters. These are broad substrate-specificity ATP-dependent efflux pumps able to export toxins or drugs out of cells; for instance, ABCB1 (MDR1, or P-glycoprotein 1), overexpressed in most cancer cells, confers them multidrug resistance (MDR). The gene coding for sorcin (SOluble Resistance-related Calcium-binding proteIN) is highly conserved among mammals and is located in the same chromosomal locus and amplicon as the ABC transporters ABCB1 and ABCB4, both in human and rodent genomes (two variants of ABCB1, i.e., ABCB1a and ABCB1b, are in rodent amplicon). Sorcin was initially characterized as a soluble protein overexpressed in multidrug (MD) resistant cells and named "resistance-related" because of its co-amplification with ABCB1. Although for years sorcin overexpression was thought to be only a by-product of the co-amplification with ABC transporter genes, many papers have recently demonstrated that sorcin plays an important part in MDR, indicating a possible role of sorcin as an oncoprotein. The present review illustrates sorcin roles in the generation of MDR via many mechanisms and points to sorcin as a novel potential target of different anticancer molecules.

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12040887DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226229PMC
April 2020

Publication Analysis

Top Keywords

novel potential
8
drug resistance
8
sorcin
7
drug
5
locus amplicon
4
amplicon abc
4
chromosomal locus
4
protein highly
4
mammals located
4
conserved mammals
4
abc transporters
4
highly conserved
4
located chromosomal
4
abcb1 abcb4
4
abcb1 abcb1a
4
abcb1a abcb1b
4
abcb1b rodent
4
rodent amplicon
4
variants abcb1
4
genomes variants
4

Similar Publications

Revealing the BRD4-NOTCH3 fusion: A novel hill in the cancer landscape.

Authors:
Fabiano de Almeida Costa Mariane Tami Amano Paula Fontes Asprino Dean C Pavlick Cibele Masotti Leonardo Testagrossa Gilberto de Castro

Lung Cancer 2021 Feb 17;154:146-150. Epub 2021 Feb 17.

Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil; Hospital Sírio-Libanês, São Paulo, Brazil.

Objectives: Gene fusions are becoming more evident in cancer scenario for either being the driver alterations, or for the great therapeutic target potential in many cases. Our aim was to characterize the BRD4-NOTCH3 fusion correlating with clinical features, and to determine the frequency of this fusion in the oncological population.

Material And Methods: One patient diagnosed with lung adenocarcinoma at Hospital Sírio-Libanês (Brazil) was included. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Novel thienopyrimidine analogues as potential metabotropic glutamate receptors inhibitors and anticancer activity: Synthesis, In-vitro, In-silico, and SAR approaches.

Authors:
Mohammed A Khedr Khadiga M Abu-Zied Wafaa A Zaghary Ahmed S Aly Dina N Shouman Hesham Haffez

Bioorg Chem 2021 Feb 16;109:104729. Epub 2021 Feb 16.

Biochemistry and Molecular Biology Department, Faculty of Pharmacy, Helwan University, P.O. Box 11795, Cairo, Egypt; Center of Scientific Excellence "Helwan Structural Biology Research, (HSBR)", Helwan University, Cairo 11795, Egypt.

There is a continuous need in drug development approach for synthetic anticancer analogues with new therapeutic targets to diminish chemotherapeutic resistance of cancer cells. This study presents new group of synthetic thienopyrimidine analogues (1-9) aims as mGluR-1 inhibitors with anticancer activity. In-vitro antiproliferative assessment was carried out using viability assay against cancer cell lines (MCF-7, A-549 and PC-3) compared to WI-38 normal cell line. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Glucose - The X factor for the survival of human fungal pathogens and disease progression in the host.

Authors:
Hafsa Qadri Munazah Fazal Qureshi Manzoor Ahmad Mir Abdul Haseeb Shah

Microbiol Res 2021 Feb 19;247:126725. Epub 2021 Feb 19.

Department of Bioresources, School of Biological Sciences, University of Kashmir, Hazratbal, Srinagar, 190006, J&K, India. Electronic address:

The incidence of human fungal infections is increasing due to the expansion of the immunocompromised patient population. The continuous use of different antifungal agents has eventually resulted in the establishment of resistant fungal species. The fungal pathogens unfold multiple resistance strategies to successfully tackle the effect of different antifungal agents. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Froth flotation of fluorite: A review.

Authors:
Zhiyong Gao Cong Wang Wei Sun Yuesheng Gao Przemyslaw B Kowalczuk

Adv Colloid Interface Sci 2021 Feb 18;290:102382. Epub 2021 Feb 18.

Department of Geoscience and Petroleum, Faculty of Engineering, Norwegian University of Science and Technology, Trondheim, Norway; Department of Analytical Chemistry and Chemical Metallurgy, Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw, Poland. Electronic address:

Fluorite, as a scarce nonrenewable strategic non-metallic mineral resource, is the primary raw material for fluorine products used in diverse fields such as metallurgy, national defense, chemical and optical industries. With the increasing expansion of the related fields, the demand for high-quality fluorite continues to grow. Hence, the surge of interest in effectively utilizing fluorite resources has led to vast attention worldwide. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

3D printing of chemical-empowered tendon stem/progenitor cells for functional tissue repair.

Authors:
Yanjie Zhang Tingyun Lei Chenqi Tang Yangwu Chen Youguo Liao Wei Ju Hong Zhang Bo Zhou Renjie Liang Tao Zhang Chunmei Fan Xiaoyi Chen Yanyan Zhao Yuanhao Xie Jinchun Ye Boon Chin Heng Xiao Chen Yi Hong Weiliang Shen Zi Yin

Biomaterials 2021 Feb 15;271:120722. Epub 2021 Feb 15.

Dr. Li Dak Sum & Yip Yio Chin Center for Stem Cells and Regenerative Medicine, Department of Orthopedic Surgery of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China; Key Laboratory of Tissue Engineering and Regenerative Medicine of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China; China Orthopaedic Regenerative Medicine (CORMed), Hangzhou, China. Electronic address:

Tendon injuries are the leading cause of chronic debilitation to patients. Tendon stem/progenitor cells (TSPCs) are potential seed cells for tendon tissue engineering and regeneration, but TSPCs are prone to lose their distinct phenotype in vitro and specific differentiation into the tenocyte lineage is challenging. Utilizing small molecules in an ex vivo culture system may be a promising solution and can significantly improve the therapeutic applications of these cells. Read More

View Article and Full-Text PDF
February 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap